Emil Tanghetti

Summary

Publications

  1. ncbi Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 10:783-92. 2011
  2. ncbi Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA, USA
    Dermatol Online J 13:1. 2007
  3. ncbi Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 9:549-58. 2010
  4. ncbi Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 7:534-8. 2008
  5. ncbi The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA, USA
    J Drugs Dermatol 11:1417-21. 2012
  6. ncbi Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial
    Emil Tanghetti
    Department of Dermatology, University of California at Davis, Sacramento, USA
    J Drugs Dermatol 5:256-61. 2006

Detail Information

Publications6

  1. ncbi Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 10:783-92. 2011
    ..Acne pathogenesis is multifactorial and includes inflammation. Combining drugs targeting multiple components of acne pathogenesis is standard practice...
  2. ncbi Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA, USA
    Dermatol Online J 13:1. 2007
    ..05). Both regimens were similarly well tolerated. In the treatment of facial acne vulgaris, tazarotene plus clindamycin offers significantly greater efficacy than tretinoin plus clindamycin and has comparable tolerability...
  3. ncbi Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 9:549-58. 2010
    ..Tazarotene 0.1% cream appeared to be more effective and nearly as well tolerated as adapalene 0.3% gel in reducing acne lesions and was more effective than adapalene 0.3% gel in reducing PIH...
  4. ncbi Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 7:534-8. 2008
    ..Benzoyl peroxide (BPO) is poorly soluble. A solubilized formulation of BPO has been developed to maximize its bioavailability and enhance follicular penetration...
  5. ncbi The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA, USA
    J Drugs Dermatol 11:1417-21. 2012
    ..Gender differences in skin and acne have been reported...
  6. ncbi Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial
    Emil Tanghetti
    Department of Dermatology, University of California at Davis, Sacramento, USA
    J Drugs Dermatol 5:256-61. 2006
    ..Any improvements in tolerability could be due to the emollients in the clindamycin/benzoyl peroxide gel formulation...